Please use this identifier to cite or link to this item:
Title: Circulating tumor cell detection during chemotherapy in patients with breast cancer is not associated with plasma homocysteine levels
Authors: Yoshihara, Renata Nunes
Teixeira, Bianca Marinelli
Adami, Fernando
Kuniyoshi, Renata K.
Alves, Beatriz C. A.
Gehrke, Flavia S.
Vilas-Boas, Viviane A.
Azzalis, Ligia A. [UNIFESP]
Junqueira, Virginia B. C. [UNIFESP]
Pereira, Edimar Cristiano [UNIFESP]
Fonseca, Fernando L. A. [UNIFESP]
ABC Med Sch
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Keywords: Breast cancer
Circulating tumor cells
Epithelial markers
Issue Date: 1-Oct-2013
Publisher: Springer
Citation: Tumor Biology. Dordrecht: Springer, v. 34, n. 5, p. 2937-2941, 2013.
Abstract: Breast cancer remains the second most frequent type of cancer in the world and the first among women, and systemic chemotherapy is an adjuvant therapeutic modality that improves survival in a great part of patients. Women with breast cancer, however, frequently show a higher risk of thromboembolism, an event associated to hyperhomocysteinemia and the presence of circulating tumor cells (CTC). Our aim is to correlate the presence of CTCs, detected by the analysis of CK19 and c-erbB2 gene expressions, and the homocysteine plasma levels in the peripheral blood in patients with breast cancer undergoing chemotherapy. Epithelial marker expression (CK19 and c-erbB2) and homocysteine levels were analyzed in a mononuclear fraction of the peripheral blood and plasma, respectively, obtained from 35 patients diagnosed with breast cancer at diagnosis and throughout chemotherapy treatment. No significant relation between the CK19 and c-erbB2 expressions and hyperhomocysteinemia was observed at any moment of the evaluation throughout the chemotherapy treatment (3 and 6 months after the onset). Among clinical data, only menopausal status showed a statistically significant correlation with homocysteine concentration. Although differences in the expressions of the analyzed epithelial markers were detected at 3 and 6 months of chemotherapy treatment, no relation between plasma homocysteine variations and the CK19 and c-erbB2 gene expressions was found in patients under chemotherapy treatment at any moment of the evaluation, suggesting that chemotherapy affects the expressions of the studied genes independently.
ISSN: 1010-4283
Other Identifiers:
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.